The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis
Abstract Background An effective vaccine against Bordetella pertussis was introduced into the Expanded Programme on Immunisation (EPI) by WHO in 1974, leading to a substantial global reduction in pertussis morbidity and mortality. In low- and middle-income countries (LMICs), however, the epidemiolog...
Main Authors: | Rudzani Muloiwa, Benjamin M. Kagina, Mark E. Engel, Gregory D. Hussey |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-020-01699-3 |
Similar Items
-
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
by: Margaret M. Williams, et al.
Published: (2016-02-01) -
Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
by: Susanna Esposito, et al.
Published: (2019-07-01) -
Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01) -
Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project
by: Veronica A. Pinell-McNamara, et al.
Published: (2017-12-01) -
Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative
by: Amar J. Chitkara, et al.
Published: (2020-07-01)